Amazon Rally or Crash: Decision Point Approaching!For Amazon, we're currently at a critical juncture with two potential scenarios:
Scenario 1 - Uptrend: This scenario suggests that Amazon has completed a five-wave cycle, finishing Wave I in September 2020, and concluded the corrective phase (Wave II) by December 2022. If this is the case, we're now in Wave III, indicated by a five-wave impulse upwards, comprising a higher Wave (1) followed by a corrective Wave (2). This scenario implies that after hitting a low at $81.43, the stock is in an uptrend. The maximum extension for this uptrend, or red Wave 5, leading to a higher Wave (1), is targeted at $181.
Scenario 2 - Ongoing Correction: Alternatively, it's posited that the overarching Wave II hasn't finished yet, and only a Wave (A) of the correction has been completed so far. Here, we anticipate the formation of Wave (B) shortly, to be followed by a Wave (C). The exact target of Wave (C) would depend on where Wave (B) concludes. For this scenario, the benchmarks for a potential Expanded Flat correction range between $177 (100% extension) and $214 (138% extension). Surpassing these values would negate the scenario of an incomplete Wave II, confirming that we are in Wave III.
The current chart patterns lean more towards the first scenario, indicating an uptrend and the end of Wave II at $81.43. The critical levels are thus set at $181 for confirming the uptrend, and between $177 to $214 for the alternate scenario. Breaking through these levels would clarify which phase Amazon is currently in.
Stockstobuy
EXAGEN (XGN) 🌶️10$-50$ target 🎯
The recent annual numbers from Exagen Inc. show promising results, with revenues exceeding forecasts by 4.4% and statutory losses per share coming in 4.4% smaller than expected. Following these results, analysts have adjusted their earnings model, with revenue forecasts for 2024 now at US$54.2 million, reflecting a 3.1% improvement compared to the last 12 months. Despite the steady losses expected, the consensus price target remains unchanged at US$5.50 per share, indicating that the business is performing in line with estimates. However, there are varying analyst views, with price targets ranging from US$5.00 to US$7.00 per share. It's worth noting that while Exagen's revenue growth is projected to slow down, the wider industry is expected to grow faster. This suggests that while Exagen's performance may be steady, it may lag behind industry peers in terms of growth.
Exxon Mobil: On the Brink of a Collapse?Having not reviewed Exxon Mobil for a while, it's important to note its strong correlation with oil prices, on which we're currently positioned in a short trade. Accordingly, we also anticipate a downward trend for Exxon Mobil that has yet to conclude. The construction of Wave E or overarching Wave (A) peaked at approximately $96. The critical question now is whether we're forming a Flat in the form of either a Regular or Expanded Flat.
We'll observe how this unfolds without making speculative judgments due to the unusual nature of witnessing an ABCDE movement towards Wave (A). Over the next year, we expect Exxon Mobil to decline, targeting a retracement between $75 and $50 as the maximum. Any level within this range presents a solid buying opportunity for a long-term investment, anticipating a robust Wave III.
AROC Possible buy opportunity Today, I am looking at Archrock Inc, with ticker AROC, for a possible upside potential. Archrock has been doing some amazing job recently, and it's seen a growth of 200% in EPS in Q4 of 2023. The company, had an average growth of earning of 115% in past three quarters, and despite gas prices falling, this company is performing well.
Where I am planning on positioning myself:
1. Weekly chart is telling me a couple of good things about this stock. First, I see increase of buying volume for this stock. Second, the stock is currently trying to break it's previous resistance level sitting at around $19 per share.
2. Daily chart, I see an ascending base pattern forming. This pattern is always bullish, and stocks which break from it on higher buying volume, tend to continue it's upside movement.
3. I will officially be waiting for the break of previous high, sitting at around $19.42 price level, for me to enter in this stock.
4. Once the break happens, I would like to see buy volume increase, this will give me a signal that this stock is the stock to be in.
5. Once I enter, my stop loss, will be sitting at around it's previous low which is at $17.70 price level.
As always, this is not a financial advice, this is just my opinion. Please do your due diligence before investing your money!
ADTN 680%+ Long-Term Trade With Risks to ConsiderADTN is approaching my buy zone between $4.79 and $5.13 near historic lows. There are four key price targets on the way up, and the highest price target gives a potential ROI of around 680% if ADTN is able to return back to previous all time highs. There are some financial risks and concerns surrounding ADTN so I recommend reading articles to better understand the situation.
Entry Price: $4.79 to $5.13
Sell Targets:
- $7.48
- $13.71
- $24.90
- $37.46
Stop Loss: $4.65
I do recommend a stop loss given the financial concerns for ADTN.
SBLK 200%+ ROI Trade Setup from Insiders in CongressNASDAQ:SBLK is gaining some attention today because Senator Tuberville has purchased $100k worth of SBLK stock, a stock that is focused on forestry and mineral shipping. Senator Tuberville sits on the Senate Committee of Forestry and Agriculture so he could have some insider knowledge here.
Buy price: $23 to $24 (I think an entry at $23 is possible, but I wouldn't mind buying at $24).
Sell targets:
- $77.50
- Previous all time highs are around $1,100.
Stop Loss: $22.50, if stopped out the re-entry price is around $16-17.
For now let's see if SBLK can get to $77.50 then we can discuss the other targets.
NATIONALUM BIG BREAKOUT & RETESTFundamental Analysis
1. Amazing Book Value
2. Nearly Zero Debt
3. Attractive Dividend Yield 3.30%(Extra Return on Holding for just 1 Quarter)
4. ROE & ROCE is Fascinating above 10-15%
5. Underperformed Like other PSUs and blasted in 2022-23, This Year Metal Sector Will Blast and Nationalum Will be Outperformer of Market
6. Sector Leader with Hindalco
7. Consistent Increasing sales and profit both QoQ and YoY also.
8. Increasing CWIP Will also create more revenue and profit.
9. More than 85-90% of holding is in Ultra strong DIIs FIIs & HNIs(Low Public(Weak) Holdings).
Technical Analysis of NATIONALUM
1. Accumulation phase is over (Big blast Breakout after 15-16 Years Like PFC, REC, TWL,MRPL, Chennpetro)
2. Successful Breakout on Daily, Weekly & Monthly TF
3.Breakout with Huge Volume happening
4. Volume Increased during Accumulation Phase from
5. Retest of Breakout Level Completed and Rejection shown on Daily TF & Buy Signal on H1 TF
Buy @ 130-135 SL - 120 Target- 250
Holding Time 3-6-9 Months
Possible Projected Loss- 10%
Probable Projected Target - More than 80%
Compass Pathways Wave Analysis: Huge Moves aheadCompass Pathways appears to have completed an impulsive 5-wave move to the upside, signaling significant strength in its recent price action. The peak of this move, reaching $12.75, is notably identified as the B wave within an extended flat correction, potentially forming part of a larger 5-wave pattern.
In anticipation of a corrective phase, I anticipate a retracement towards the 0.618 - 0.65 Fibonacci ratio. This level coincides with a point of demand established in May 2022, which has historically served as a robust support level. Therefore, I am targeting a correction to the range of $6.86-7.06, presenting a compelling buying opportunity. This represents a potential decrease of approximately 30.7% to 29.1% from the current price of $9.90.
Looking ahead, my projections for subsequent waves are as follows:
Low: $21.07 (+112.8%)
Medium: $29.68 (+199.8%)
High: $41.80 (+322.2%)
Moonshot: $120 (+1,111.1%)
It's essential to note that the realization of these targets will be contingent upon the outcome of Compass Pathways' significant psilocybin phase 3 trial, slated for release by year-end. Regardless of the trial's results, I anticipate a substantial increase in price leading up to the release date, driven by market anticipation and sentiment.
In summary, while Compass Pathways demonstrates considerable strength in its recent price movements, caution is advised as the stock may undergo a corrective phase towards identified support levels before potentially resuming its upward trajectory, influenced by the impending trial results.
AVD Great Buy Between $9.56 and $10.58.AVD has three simple trading levels and is trading near the lows around $9.56 to $10.58. There are long wicks down to $9.56 and below for the best entry opportunities. I think AVD could present a buy opportunity over the next few weeks or months and I would be willing to buy around $9.56 or lower. For now there has been a missed opportunity and AVD is trending up. I would wait for a pullback though.
LSF's Bullish Rebound and 2000%+ Long-Term Growth PotentialLSF reported strong earnings this week and had a very bullish rebound. I think LSF was a dead stock, and this week is likely to capture a lot of attention and interest. The weekly candle has broken through numerous resistance levels and there is little resistance on the way up to previous all time highs at $56. This is a 2000%+ growth potential from current price levels, but I think there could be a pullback first and a lower price entry. I would buy and hold to new all time highs for this one. I definitely recommend doing some research as well to see why there has been such a bullish week.
COCR.N0000Wait for pullback to 30
Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
EXPO.N0000 - How to buy and sellBuy and Sell zones mentioned in the chart.
Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
BIL.N0000 - Strong Support, Buy and Sell ZonesIf you missed the chance to buy BIL less than 5, you can wait for a pullback to buy zone in the chart.
Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
INFOSYS (INFY) Big Bullish Move is coming soonFundamentals of Company
1. Consistent Growth of Company & Increasing Profits Year on Year
2. Great to Fair Valuation
3. Strong Big Players Holding
4.Robust management
5.IT Sector is Outperforming & Flourishing
Technical Factors for Buying
1. Completion of Accumulation & Formation of HH + HLs on Daily & Weekly TF
2. Retest of major breakout completed
3. Bullish pattern Formation on Daily TF on 7 Mar 24.
4. Wick & Strong rejection on Weekly TF
5. All Momentum & Price based Indicators are also in buying direction
ALL TIME HIGH BREAKOUT STOCKNSE:HAVELLS
All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
ALL TIME HIGH BREAKOUT NSE:TATASTEEL
All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
NYKAATechnical Data
1.Accumulation Phase of About 1 Year
2.Increased Volume during Accumulation Phase
3.Big Breakout on Weekly TF with Big Volume
4. Retest of This phase is also done
5. Price Respected Breakout zone of 150-155
6. Rejection & Buying Confirmed on Weekly TF
Fundamental Data Analysis
1.Company is posting Increased Quarterly Results
2.Fundamentals & Company management is strong
3.Big Institutions also increasing stakes continuously
4. Kind of monopoly listed player in Market
(Study BSE for monopoly listed player)
5. Consistently growing business & market share
Buy at CMP @155-157
SL- @135
Target 1-310 (100% Returns)
Target 2 - 410 (More than 150%)
Time Period- Next 6-12 Months
LSXMA - Good Upside PotentialLSXMA broke the parallel channel that was holding the price since November 2022 after making a double bottom with the March 2020 low, I also liked the fact that the 2D SMMA was also broken, after having served as resistance since January 2023 and it is currently retesting it, and as if that wasn't enough to be bullish, LSXMA had a bullish divergence on the RSI on the weekly time frame.
I believe that if the LSXMA price holds above the parallel channel (SMMA), it could be the beginning of a new up trend, and could give good gains in the medium term.
ALL TIME HIGH BREAKOUT STOCKNSE:DCAL
All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.